The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats

Polish Journal of Pharmacology

Volumn 49, Issue 1, 1997, Pages 21-30

  Filip, Małgorzata ^a   Przegaliński, Edmund ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

amphetamine; cocaine; dopamine (DA) receptor subtypes; drug discrimination; rats

Indexed keywords

2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; BROMOCRIPTINE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR; PRAMIPEXOLE; RACLOPRIDE; RECEPTOR SUBTYPE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG ANTAGONISM; DRUG DISCRIMINATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

AMPHETAMINE; ANIMALS; COCAINE; CUES; DISCRIMINATION (PSYCHOLOGY); DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 1842410750     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. 3 receptor ligands. Eur. J. Pharmacol., 1995, 281, R7-R9.
2. 1 receptor efficacy. Eur. J. Pharmacol.-Molec. Pharm., 1990, 188, 335-347.
3. Arnt J.: The discriminative stimulus properties of the D-1 agonist SK&F 38393 and the D-2 agonist (-)-NPA are mediated by separate mechanism. Life Sci., 1988, 42, 565-574.
4. Arnt J., Perregaard J.: Synergistic interaction between dopamine D-1 and D-2 receptor agonists: circling behaviour of rats with hemitransection. Eur. J. Pharmacol., 1987, 143, 45-53.
5. Barone P., Davis T. A., Braun A. R., Chase T. N.: Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions. Eur. J. Pharmacol., 1986, 123, 109-114.
6. Barrett R. L., Appel J. B.: Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine. Psychopharmacology, 1989, 99, 13-16.
7. Broadbent J., Michael E. K., Riddle E. E., Appel J. B.: Involvement of dopamine uptake in the discriminative stimulus effects of cocaine. Behav. Pharmacol., 1989, 2, 187-197.
8. Callahan P. M., Appel J. B., Cunningham K. A.: Dopamine D-1 and D-2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology, 1991, 103, 50-55.
9. 2 receptor function in rats. J. Pharmacol. Exp. Ther., 1993, 266, 585-592.
10. 2C receptors. J. Pharmacol. Exp. Ther., 1995, 274, 1414-1424.
11. 1 receptors in the nucleus accumbens. Psychopharmacology, 1994, 115, 110-114.
12. Callahan P. M., Piercey M. F., Cunningham K. A.: Effects of the putative dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 on the discriminative stimulus properties of cocaine. Psychopharmacology, 1992, 107, 73-77.
13. 2 receptors appears necessary for full expression of postsynaptic effects of dopamme agonists: a neurophysiological study. Brain Res., 1987, 400, 205-218.
14. 3 dopamine receptors in human striatum. Prog. NeuroPsych. Biol. Psych., 1995, 19, 1147-1154.
15. Di Chiara G., Imperato A.: Drugs of abuse preferentially stimulate DA release in the mesolimbic system of freely moving rats. Proc. Nat. Acad. Sci. USA, 1988, 85, 5274-5278.
16. Di Ciano P., Coury A., Depoortere R. Y., Egilmez Y., Lane J. D., Emmett-Oglesby M. W., Lepiane F. G., Phillips A. G., Blada C. D.: Comparison of changes in extracellular dopamine concentrations in the nucleus accumbens during intravenous self-administration of cocaine or d-amphetamine. Behav. Pharmacol., 1995, 6, 311-322.
17. 2 receptors in mediating the d-amphetamine discriminative cue. Eur. J. Pharmacol., 1991, 202, 191-199.
18. 3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats. Eur. J. Pharmacol., 1994, 261, 327-331.
19. 3 receptor ligand, (+)-UH 232, is a partial agonist. Eur. J. Pharmacol., 1995, 282, R3-R4.
20. 3 receptor and schizophrenia: pharmacological, anatomical and genetic approaches. Eur. Neuropsychopharmacol., 1995, Suppl. 3-9.
21. Hyttel J.: SCH 23390 - the first selective dopamine D-1 antagonist. Eur. J. Pharmacol., 1983, 91, 153-154.
22. Iorio L. C., Barnett A, Leitz F. H., Houser V. P., Korduba C. A.: SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J. Pharmacol. Exp. Ther., 1983, 226, 462-468.
23. Kelly E., Nahorski S. R.: Endogenous dopamine functionally actives D-1 and D-2 receptors in striatum. J. Neurochem, 1987, 49, 115-120.
24. 3H-raclopride. Biochem. Pharmacol., 1985, 34, 2251-2259.
25. 1 receptors in the nucleus accumbens of rats is due to stimulation of these receptors in the shell, but not the core, of this nucleus. Psychopharmacology, 1996, 126, 185-190.
26. 3 receptor binding affinities. Eur. J. Pharmacol., 1995, 277, 209-214.
27. Kuczenski R., Segal. D. S.: Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmacol. Exp. Ther., 1992, 262, 1085-1094.
28. Kuczenski R., Segal D. S., Aizenstein M. L.: Amphetamine cocaine and fencamfamine: relationships between locomotor and stereotypy response profiles and caudatae and accumbens dopamine dynamics. J. Neurosci., 1991, 9, 2051-2065.
29. Kuhar M. J., Ritz M. C., Boja J. W.: The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci., 1991, 14, 299-302.
30. 3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline. Psychopharmacology, 1996, 124, 306-314.
31. 2 behavioral actions. Eur. J. Pharmacol., 1984, 101, 159-160.
32. Markstein R.: Neurochemical effects of some ergot derivatives: a basis for their antiparkinson actions. J. Neural Transm., 1981, 51, 39-59.
33. McKenna M. L., Ho B. T.: The role of dopamine in the discriminative stimulus properties of cocaine. Neuropharmacology, 1980, 19, 297-303.
34. 2 antagonist. Acta Neurobiol. Exp., 1996, 56, 897-905.
35. 4 receptors. Eur. J. Pharmacol., 1995, 290, 29-36.
36. 2 receptors elicit prolactin secretion and catalepsy. J. Pharmacol. Exp. Ther., 1995, 275, 885-898.
37. Nielsen E. B., Andersen P. H.: Drug discrimination approaches to the behavioral role of the D-1 receptor. J. Psychopharmacol., 1992, 6, 43-49.
38. Nielsen E. B., Randrup K., Andersen P. H.: Amphetamine discrimination: effects of dopamine receptor agonists. Eur. J. Pharmacol., 1989, 160, 253-262.
39. Nielsen E. B., Scheel-Krüger J.: Cueing effects of amphetamine and LSD: elicitation by direct microinjection of the drugs into the nucleus accumbens. Eur. J. Pharmacol., 1986, 125, 85-92.
40. 2 receptors: comparisons with SCH 23390. Eur. J. Pharmacol., 1984, 98, 433-436.
41. 2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions. Psychopharmacology, 1986, 90, 287-294.
42. Reith M. E. A., Meisler B. E., Sershen H., Lajtha A.: Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem. Pharmacol., 1986, 35, 1123-1129.
43. Richardson N. R., Piercey M. F., Svensson K., Collins R. J., Myers J. E., Roberts D. C. S.: Antagonism of cocaine self-administration by the preferential dopamine autoreceptor antagonist, (+)-AJ 76. Brain Res., 1993, 619, 15-21.
44. Ross S. B., Renyi A. L.: Accumulation of tritiated 5-hydroxytryptamine in brain slices. Life Sci., 1967, 6, 1407-1415.
45. 2 receptors. NeuroReport, 1995, 6, 329-332.
46. 3 receptor and its relevance in psychiatry. Int. Clin. Psychopharmacol., 1995, 10 Suppl., 15-20.
47. Setler P. E., Saru H. M., Zirkle C. L., Saunders H. L.: The central effects of a novel dopamine agonist. Eur. J. Pharmacol., 1978, 50, 419-430.
48. Smith A., Piercey M., Roberts D. C. S.: Effect of (-)-DS 121 and (+)-UH 232 on cocaine self-administration in rats. Psychopharmacology, 1995, 120, 93-98.
49. 3) as a target for neuroleptics. Nature, 1990, 347, 146-151.
50. Sokoloff P., Schwartz J.-C.: Novel dopamine receptors half a decade later. Trends Pharmacol. Sci., 1995, 16, 270-275.
51. 3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. J. Pharmacol. Exp. Ther., 1996, 278, 1128-1137.
52. 3 receptors. Eur. J. Pharmacol., 1994, 263, 235-243.
53. 3 receptor-mediated increase in the release of oxytocin in the male rat. Neuroendocrinology, 1995, 6, 1338-1340.
54. Waters N., Hansson L., Löfberg L., Carlsson A.: Intracerebral infusion of (+)-AJ 76 and (+)-UH 232: effects on dopamine release and metabolism in vivo. Eur. J. Pharmacol., 1994, 251, 181-190.
55. White F. J.: D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist. Eur. J. Pharmacol., 1987, 135, 101-105.
56. 2 receptors in the drug discrimination paradigm. Behav. Neural Biol., 1990, 53, 378-392.
57. Witkin J. M., Nichols D. E., Terry Ph., Katz J. L.: Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J. Pharmacol. Exp. Ther., 1991, 257, 706-713.
58. Wood D. M., Emmett-Oglesby M. W.: Mediation in the nucleus accumbens of the discriminative stimulus produced by cocaine. Pharmacol. Biochem. Behav., 1989, 33, 453-457.
59. Woolverton W. L., Johnson K. M.: Neurobiology of cocaine abuse. Trends Pharmacol. Sci., 1992, 13, 193-200.